Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with locally advanced non-small cell lung cancer (a specific type of lung cancer) at a certain stage (stage IIB to IIIB), confirmed by a lab test of tissue or cell samples
- People who are relatively active and able to carry out daily activities with little or no difficulty (this is measured on a standard 0–1 scale used by doctors)
- People who are able to follow the treatment plan and attend all required study and follow-up appointments
- Women who have a negative pregnancy test result
- People who have read and signed a consent form agreeing to take part in the study
- People whose treatment plan includes a specific type of radiation therapy (66 Gy given in 33 sessions) that meets safety limits for the surrounding healthy tissue
Who may not be able to join:
- People who have an unstable ongoing health condition, such as an active infection, unstable chest pain, heart failure, or severe liver, kidney, or metabolic disease
- People who need oxygen supplied through a nasal tube to breathe
- People who have previously had radiation therapy to the chest area, unless there is no meaningful overlap with the area that would be treated in this trial (confirm with trial site)
- People who currently have another active cancer
- People who are unable to swallow oral medications or who need to be fed through a drip (intravenous nutrition)
- People who have an ulcer
- Women who are currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +4565411867
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Locoregional control (Tumor recurrency is assessed by scheduled CT (of the thorax and upper abdomen)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.